BioSpace News Archive

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today a distribution agreement with Mobile Aspects for its iRIScope software and iRIScope cabinets product lin

Diomics Announces Agreement With Department of Defense to Accelerate Development and Testing of Diocheck ™ SARS-CoV-2 Immune Response Indicator Patch Simple Skin Patch Empowers Individuals to Monitor for Immune Response to Help Stop COVID-19 Spread SAN DIEGO--( BUSINESS WIRE )-- Diomics, a San Diego-based biotech company, today announced that it has been awarded a $2,125,000 Medical Technology Enterprise Consortium (MTEC) Other Transaction Agree

ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, today introduces the industry’s thinnest dedicated sensor for blood oxygen saturation (SpO2) measurement, bringing the capability to remotely monitor this vital sign to small consumer products such as earbuds, smart watches and wristbands, as well as to medical devices such as patches and oximeters

Coming Sept. 26, Queen Latifah hosts livestream fundraiser on Facebook Live with celebrity guests to support communities hardest hit by COVID-19 pandemic [17-September-2020] CHICAGO , Sept. 17, 2020 /PRNewswire/ -- Today the American Lung Association announced Common, Harry Connick Jr. and Adam Rippon will be participating in #Act4Impact , a livestream fundraisin

North County Biotech Laboratories (NCBL), provider of fully equipped, private, and secure laboratories with offices in North County San Diego for development and growth of innovative, novel therapies and medicines, announces immediate availability.

Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2020 third quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday , October 27, 2020, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Michael F. Neidorff , Chairman, Presiden

410 Medical, a medical device company developing innovative products for resuscitation of critically ill patients, is pleased to announce the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for a new product in the LifeFlow family.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today announced that CEO, John Climaco, will present virtually at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Tuesday

Belong.Life (Belong), a developer of social and professional networks for managing and navigating treatments, and the creator of the world’s largest social network for cancer patients has published a study showing that almost half of cancer patients receiving immunotherapy and suffering from Financial Toxicity (FT) were not aware of the possible development of FT prior to treatment.

-- BLU-945 demonstrates potent EGFR pathway inhibition against on-target resistance mutations -- -- BLU-945 shows exquisite wild-type EGFR and kinome selectivity, enabling potential for combination strategies -- -- Plan to initiate international Phase 1 dose-escalation trial of BLU-945 in patients with treatment-resistant EGFR-mutated NSCLC in 1H 2021 -- [17-September-2020]